Impact of diabetes on recurrence of hepatocellular carcinoma after surgical treatment in patients with viral hepatitis.
OBJECTIVE
Consensus has been reached that diabetes is a risk factor for development of HCC, but the impact on postoperative recurrence is still controversial. To clarify this point, we analyzed the relationship of postoperative recurrence rate of HCC and coexistence of diabetes in the patients with viral hepatitis.


METHODS
A total of 90 patients who had undergone curative resection for HCC were analyzed. They were divided into two groups with and without diabetes, and the recurrence-free survival rates after surgical treatment and the factors contributing to recurrence were examined.


RESULTS
Kaplan-Meier survival analysis showed the recurrence-free survival rates in the diabetic group were significantly lower than those in the nondiabetic group (P= 0.005) and overall survival rates in the diabetic group were significantly lower than those in the nondiabetic group (P= 0.005). These results were emphasized in the analysis of patients infected with hepatitis C virus. Univariate and multivariate analyses showed diabetes was a significant factor contributing to HCC recurrence after treatment. Furthermore, multivariate analysis in HCC patients with diabetes showed Child-Pugh classification B (P= 0.001) and insulin therapy (P= 0.049) were significant factors contributing to HCC recurrence after treatment.


CONCLUSIONS
The results of the present study suggest that diabetes is a risk factor for the recurrence of HCV-related HCC and decreases the overall survival rates after surgical treatment. HCV-related HCC patients with diabetes should be closely followed for postoperative recurrence.
Komura
Takuya
T
Department of Gastroenterology, Graduate School of Medicine, Kanazawa University, Kanazawa, Ishikawa, Japan.
Mizukoshi
Eishiro
E
Kita
Yuki
Y
Sakurai
Masaru
M
Takata
Yoshiko
Y
Arai
Kuniaki
K
Yamashita
Tatsuya
T
Ohta
Tetsuo
T
Shimizu
Koichi
K
Nakamoto
Yasunari
Y
Honda
Masao
M
Takamura
Toshinari
T
Kaneko
Shuichi
S
D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000401:mortality / Q000473:pathology* / Q000821:virology; D048909:Diabetes Complications; D005260:Female; D006498:Hepatectomy; D006525:Hepatitis, Viral, Human / Q000150:complications*; D006801:Humans; D008113:Liver Neoplasms / Q000150:complications* / Q000401:mortality / Q000821:virology; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D016019:Survival Analysis; D015996:Survival Rate